Medifast, Inc. (MED)

Medifast Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	94.44	87.69	104.18	163.72	76.97
Short-Term Investments	55.6	0	5.36	10.75	15.7
Cash & Cash Equivalents	150.04	87.69	109.54	174.48	92.68
Cash Growth	71.10%	-19.95%	-37.22%	88.26%	-8.27%
Receivables	0	0	0	0	1.44
Inventory	54.59	118.86	180.04	53.39	48.77
Other Current Assets	19.4	16.24	17.28	6.45	11.27
Total Current Assets	224.03	222.78	306.87	234.31	154.15
Property, Plant & Equipment	67.11	75.65	80.59	38.14	38.84
Other Long-Term Assets	18.77	17.78	10.87	3.63	1.66
Total Long-Term Assets	85.88	93.43	91.46	41.77	40.5
Total Assets	309.91	316.21	398.33	276.08	194.65
Accounts Payable	86.42	134.69	163.31	107.68	76.22
Current Debt	5.89	5.78	6.52	3.67	3.17
Other Current Liabilities	0	0.43	0	0	0
Total Current Liabilities	92.3	140.89	169.83	111.35	79.39
Long-Term Debt	16.13	20.28	26.02	7.49	10.43
Total Long-Term Liabilities	16.13	20.28	26.02	7.49	10.43
Total Liabilities	108.43	161.17	195.85	118.84	89.82
Total Debt	22.01	26.05	32.54	11.16	13.6
Debt Growth	-15.50%	-19.95%	191.58%	-17.94%	-
Retained Earnings	174.65	139.85	190.33	154.35	168.79
Comprehensive Income	0.25	0.02	0.11	0.04	0.03
Shareholders' Equity	201.48	155.04	202.47	157.25	104.83
Net Cash / Debt	128.03	61.64	77	163.31	79.08
Net Cash / Debt Growth	107.70%	-19.95%	-52.85%	106.53%	-21.73%
Net Cash Per Share	11.72	5.47	6.52	13.78	6.53
Working Capital	131.73	81.89	137.03	122.96	74.76
Book Value Per Share	18.51	13.85	17.30	13.36	8.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).